Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Analysis of the (Lymph-)Angiogenic Potential of Regenerative Scaffolds and the Impact of Adipose-Derived Mesenchymal Stem Cells.

Koll KK., Klevansky DA., Kasakovski D., Ahmadzadeh N., Will PA., Kneser U.

Animal Study on Chronic Wound, published in Plast Reconstr Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Plast Reconstr Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40178869
DOI
10.1097/PRS.0000000000012131
Citations
1

Abstract (original English)

Background Regenerative matrices are essential in the therapy of complex wounds, where lymphangiogenesis and angiogenesis play crucial roles. This work investigates the lymph and angiogenic potential of regenerative scaffolds and the influence of adipose-derived mesenchymal stem cells (ADSC) in a rodent wound model. Methods In a wound model, the authors administered different acellular dermal matrices (ADMs) to 2 wounds on each rat-enriching 1 with ADSCs and leaving the other without. ADSCs were isolated from rodent inguinal fat tissue, characterized using fluorescence-activated cell sorting and their viability confirmed in vitro on different matrices. Tissue samples were collected on days 7, 14, 21, and 28 postoperatively. Six different ADMs, including 2 synthetic and 4 biological variants, were compared using histologic, immunofluorescence staining, and molecular biological analyses. Results ADM integration varied, with collagen (COL)-elastin-ADM showing the highest integration (95%) and polyurethane (PU)-ADM, the lowest (23%) after 7 days. Synthetic ADMs, particularly PU-ADM, exhibited the highest mRNA expression of angiogenesis and lymphangiogenesis markers at 7 and 28 days. Protein analysis showed that synthetic ADMs had the highest CD31 levels from 14 to 28 days, whereas COL-ADM had the highest LYVE1 and PROX1 levels at 21 and 28 days. Immunofluorescence revealed polylact

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsLymphangiogenesisTissue ScaffoldsRatsAdipose TissueMesenchymal Stem CellsMesenchymal Stem Cell TransplantationNeovascularization, PhysiologicMaleWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research